K
Kwang Hyub Han
Researcher at Yonsei University
Publications - 694
Citations - 36674
Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.
Papers
More filters
Journal ArticleDOI
Epidemiology of hepatocellular carcinoma in Japan and Korea
TL;DR: With the enormous efforts of researchers devoted to basic and clinical studies, the incidence of HCC is expected, in the near future, to gradually decline in Japan and Korea.
Journal ArticleDOI
Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
Beom Kyung Kim,Hyon Suk Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Chae Yoon Chon,Young Nyun Park,Kwang Hyub Han,Seung Up Kim +8 more
TL;DR: ELF demonstrated considerable diagnostic value in fibrosis staging in Asian chronic hepatitis B patients, especially in predicting F≥2, but LSM consistently provided better performance for predicting F¬3 and F4.
Journal ArticleDOI
Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
TL;DR: The role of transient elastography (TE) in monitoring liver stiffness and determining prognosis in patients with chronic hepatitis B (CHB) or chronic hepatitis C (CHC) who are undergoing antiviral treatment has been investigated as mentioned in this paper.
Journal ArticleDOI
Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.
Beom Kyung Kim,Do Young Kim,Kwang Hyub Han,Jun Yong Park,Ja Kyung Kim,Yong Han Paik,Kwan Sik Lee,Chae Yoon Chon,Sang Hoon Ahn +8 more
TL;DR: LSPS is a reliable predictor for EVB risk and according to risk stratification, different prophylactic treatments should be considered for subgroups with LSPS≥6.5.
Journal ArticleDOI
CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice.
Yang Gun Suh,Ja Kyung Kim,Jin-Seok Byun,Hyon-Seung Yi,Young Sun Lee,Hyuk Soo Eun,So Yeon Kim,Kwang Hyub Han,Kwan Sik Lee,Gregg Duester,Scott L. Friedman,Won-Il Jeong +11 more
TL;DR: The early impact of BMC infusion is analyzed and subsets of BMCs showing antifibrotic effects in mice with carbon tetrachloride–induced liver fibrosis are identified, and Activated HSCs increase IL‐10 expression in BMCs (CD11b+Gr1highF4/80− and CD11b-Gr1+F 4/80+ cells), which in turn ameliorates liver fibritis.